Gufic BioSciences standalone net profit rises 1.16% in the June 2024 quarter
Net profit of Gufic BioSciences rose 1.16% to Rs 20.86 crore in the quarter ended June 2024 as against Rs 20.62 crore during the previous quarter ended June 2023. Sales rose 3.99% to Rs 202.81 crore in the quarter ended June 2024 as against Rs 195.02 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 202.81 | 195.02 | 4 |
OPM % | 17.65 | 18.19 | - |
PBDT | 32.42 | 32.29 | 0 |
PBT | 28.11 | 28.05 | 0 |
NP | 20.86 | 20.62 | 1 |
![blog-article-image-one](/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fblinktradecmsprod%2FStocks_258031f448%2FStocks_258031f448.png&w=256&q=75)
Low Price Shares
0 mins read . Dec 18, 2024
![blog-article-image-one](/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fblinktradecmsprod%2FBest_Stocks_Under_10_Rupees_in_India_be7ded3097%2FBest_Stocks_Under_10_Rupees_in_India_be7ded3097.webp&w=256&q=75)
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
![blog-article-image-one](/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fblinktradecmsprod%2FBest_Stocks_Under_100_in_India_2024_ef4b01fbcf%2FBest_Stocks_Under_100_in_India_2024_ef4b01fbcf.jpg&w=256&q=75)
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
₹0 Brokerage *
Open Demat Account